Apellis Pharmaceuticals, Inc. Insider Transactions
Apellis Pharmaceuticals, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Francois Cedric
CEO |
Sell | 2,843 @ $64.14 | $182,345 | 317,624 | 01/29/2024 | 01/31/2024 | |
|
Eisele Jeffrey
Chief Development Officer |
Sell | 279 @ $64.14 | $17,895 | 58,179 | 01/29/2024 | 01/31/2024 | |
|
Deschatelets Pascal
Chief Scientific Officer |
Sell | 874 @ $64.14 | $56,057 | 1,117,131 | 01/29/2024 | 01/31/2024 | |
|
DeLong Mark Jeffrey
Chief Business & Strat Officer |
Sell | 367 @ $64.14 | $23,539 | 65,203 | 01/29/2024 | 01/31/2024 | |
|
Lewis Karen
Chief People Officer |
Sell | 4,286 @ $63.69 | $272,975 | 47,637 | 01/23/2024 | 01/24/2024 | |
|
Eisele Jeffrey
Chief Development Officer |
Sell | 7,378 @ $63.69 | $469,905 | 58,458 | 01/23/2024 | 01/24/2024 | |
|
Francois Cedric
CEO |
Sell | 13,431 @ $65.00 | $872,961 | 320,467 | 01/22/2024 | 01/23/2024 | |
|
Watson David O.
General Counsel |
Sell | 4,184 @ $65.00 | $271,943 | 105,077 | 01/22/2024 | 01/23/2024 | |
|
Townsend Adam J.
Chief Commercial Officer |
Sell | 3,413 @ $65.00 | $221,831 | 94,507 | 01/22/2024 | 01/23/2024 | |
| Sell | 3,551 @ $65.00 | $230,801 | 95,675 | 01/22/2024 | 01/23/2024 | ||
|
Nicholson Nur
Chief Technical Officer |
Sell | 2,593 @ $65.00 | $168,535 | 68,342 | 01/22/2024 | 01/23/2024 | |
|
Lewis Karen
Chief People Officer |
Sell | 1,738 @ $65.00 | $112,963 | 51,923 | 01/22/2024 | 01/23/2024 | |
|
Eisele Jeffrey
Chief Development Officer |
Sell | 1,607 @ $65.00 | $104,449 | 65,836 | 01/22/2024 | 01/23/2024 | |
|
Deschatelets Pascal
Chief Scientific Officer |
Sell | 3,913 @ $65.00 | $254,329 | 1,118,005 | 01/22/2024 | 01/23/2024 | |
|
DeLong Mark Jeffrey
Chief Business & Strat Officer |
Sell | 1,384 @ $65.00 | $89,954 | 65,570 | 01/22/2024 | 01/23/2024 | |
|
Chopas James George
VP/CAO |
Sell | 1,061 @ $65.00 | $68,961 | 39,067 | 01/22/2024 | 01/23/2024 | |
|
Eisele Jeffrey
Chief Development Officer |
Sell | 5,207 @ $65.58 | $341,475 | 67,443 | 01/17/2024 | 01/18/2024 | |
|
Lewis Karen
Chief People Officer |
Sell | 3,276 @ $65.58 | $214,840 | 53,661 | 01/17/2024 | 01/18/2024 | |
|
Deschatelets Pascal
Chief Scientific Officer |
Sell | 1,632 @ $66.81 | $109,032 | 1,121,918 | 01/16/2024 | 01/17/2024 | |
|
Chopas James George
VP/CAO |
Sell | 864 @ $66.81 | $57,723 | 40,128 | 01/16/2024 | 01/17/2024 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Apellis Pharmaceuticals, Inc. FAQ's
The list of insiders at Apellis Pharmaceuticals, Inc. includes Chopas James George, DeLong Mark Jeffrey, Dunlop A. Sinclair, Sullivan Timothy Eugene, Deschatelets Pascal.
Insiders have sold a total of 255,534 Apellis Pharmaceuticals, Inc. shares in the last 12 months for a total of 11.78 M sold.
The following insiders have sold Apellis Pharmaceuticals, Inc. shares in the last 12 months: Chopas James George ($39,060), DeLong Mark Jeffrey ($564,050), Dunlop A. Sinclair ($3.86 M), Sullivan Timothy Eugene ($234,640), Deschatelets Pascal ($7.09 M),